Cu-NuriPro™ detected more lesions up to 4 hours post-administration in 50% of patients, not visualized by 18F-piflufolastat PET1,2 Dosimetry data highlight favorable tumor-to-background ratio with ...

Contest Honors Hospitals for Healing Design, Compassionate Care, and Community ImpactAtlanta, GA, June 23, 2025 (GLOBE NEWSWIRE) -- Soliant Health, a leading healthcare and education staffing provider ...